Even though Advair’s main patent expired in 2010 and the patent on the Diskus inhaler expired in 2016, until now no-one has managed to get the FDA to approve a cheaper copy of the drug-device ...
“We expect the recently approved generic Advair to have minimal impact on this highly differentiated product, the first approved once daily single inhaler triple therapy for COPD,” said GSK ...
The Schmidtknechts’ lawsuit alleged their son was not notified by his insurance or Walgreens ahead of time that his inhaler ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is ... daily from a Diskus™ inhaler for a 4-week run ...
GSK, the manufacturer of Advair, is not named in the lawsuit ... history and can confirm that he did fill a generic Albuterol prescription, an inhaler used to stop asthma attacks, on January ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results